chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Saturday, 01/09/21 1300-received 2nd vaccine Sunday, 01/10/21 0500 -severe left arm pain, began at injection site, radiated: up and across L shoulder blade area, up neck and into head, down to L fingertips 0600 -all above continued, R knee joint pain (sharp/stabbing) 1400 -all above continued except R knee joint pain; spinal pain and intercostal pain began 1900 -all above continued; TMJ, jaw, and 'tooth' pain began Monday, 1/11/21 TMJ, jaw, and 'tooth' pain, nausea, fatigue, night sweat Tuesday, 1/12/21 TMJ, jaw, and 'tooth' pain, nausea, fatigue, night sweat Went to dentist (scheduled appointment on Monday) for cleaning and thorough exam...exam was normal Wednesday, 1/13/21 continuation of symptoms from 1/12/21, but pain worse, ear pain Thursday, 1/14/21 0630 had eaten a full can of chicken noodle soup. Was sitting and working on CEs for work, had taken medications for the day, but added in hydrocodone, half of a 7.5/325mg tablet and ibuprofen 200mg. Felt a severe wave of nausea. Laid my head down on my arms on the table. Do not remember getting up, but remember walking through the kitchen in front of the refrigerator, reaching up to feel my pulse, felt two beats which were too far apart and thought to myself, "I'm going to faint". Apparently I was able to walk about 6 feet further, but I don't remember it. I don't know what time I fainted, but I think I must have fallen. I woke up sometime after 7, disoriented and my head hurt, lying on the kitchen floor. My husband came to my side after I called out to him about 5 times. I was drenched in sweat and very weak. When firefighters arrived they said my heart rate was 'all over the place', from 46 to I don't know what (did not hear). Ambulance arrived around 0730. Glucose was normal. Was taken for evaluation. Was given IV NS (I think 1000mls). Labwork was drawn. CXR, CT, and EKG. ER Dr recommended I follow up with my cardiologist, as she noted mitral valve regurgitation and thought a Holter monitor would be advisable. CXR and CT normal. EKG normal sinus rhythm, but showed anteroseptal infarct of unknown age, confirmed by cardiologist who read the EKG. Also seen by my PCP at 1430, he checked my ears, as they had been hurting as well, said they were clear. Advised alternating tylenol and ibuprofen Q4-6H. Friday and Sunday 1/15 and 1/16 night sweat, TMJ pain, nauseated, headache, neckache, fatigue, shoulders sore, eyes sore, inner ear pain Sunday, 1/17 0500 woke up, lying in bed, dizzy, clammy palms, chest pain (mid-clavicular, just below left breast, stabbing), night sweat, TMJ pain, nauseated, headache, neckache, fatigue, L & R flank pain, BP 115/70, HR 54 Monday 1/18, Tuesday, 1/19, Wednesday 1/20, Thursday 1/21, Friday 1/22, and Saturday 1/23 varying degrees of: fatigue, nausea, dizziness, TMJ, jaw, and 'tooth' pain, palpitations, and ear pain. TMJ and jaw pain worsens with activity.
Devel fever of 105 ax approx 18 hrs p/immun were given in spite of APAP;
Myalgia; Left arm was really red; Left arm was hot; left arm was swollen to the size of a baseball; Achy joints; Really tired; Nausea due to the pain; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of MYALGIA (Myalgia) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J202A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history.).    On 28-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MYALGIA (Myalgia). At the time of the report, MYALGIA (Myalgia) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. No treatment information was provided.  Company comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 07-Jan-2021: No specific follow-up information recorded.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Has itchy and bumps; Mark from band aid; Injection site warmth; Has itchy and bumps; Redness by her injection site; Injection site soreness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAPULE (Has itchy and bumps), VACCINATION SITE SCAR (Mark from band aid), VACCINATION SITE WARMTH (Injection site warmth), VACCINATION SITE PRURITUS (Has itchy and bumps) and VACCINATION SITE ERYTHEMA (Redness by her injection site) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced VACCINATION SITE PAPULE (Has itchy and bumps), VACCINATION SITE SCAR (Mark from band aid), VACCINATION SITE WARMTH (Injection site warmth), VACCINATION SITE PRURITUS (Has itchy and bumps), VACCINATION SITE ERYTHEMA (Redness by her injection site) and VACCINATION SITE PAIN (Injection site soreness). At the time of the report, VACCINATION SITE PAPULE (Has itchy and bumps), VACCINATION SITE SCAR (Mark from band aid), VACCINATION SITE WARMTH (Injection site warmth), VACCINATION SITE PRURITUS (Has itchy and bumps), VACCINATION SITE ERYTHEMA (Redness by her injection site) and VACCINATION SITE PAIN (Injection site soreness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications was provided. No laboratory details was reported. No treatment information was provided.
Injection site slightly swollen, c/o hives on lower arms and legs "felt itchy inside".  Symptoms persisted for 3 days.  Treated with Benadryl.
Patient reported that she developed a rash which we had discussed as a potential adverse event. She reported she also went unconscious and was brought to the hospital as she was non-responsive. She was held overnight for observation then released the next day. Per patient she didn't remember which pharmacy she received the shot at (it was ours) and she said she was also taking a medication (did not elaborate on what it was) and wasn't sure if that could have been the cause as we discussed that it would be rare to have that kind of side effect. The rash was still present and did not look like hives but rather a mild redness over her forearm - resembling sunburn. I asked the patient if she had had any difficulty breathing - swelling in her throat - and she said "well I went unresponsive, so yes". Patient still appeared fatigued and a little confused when reporting the incident. I asked if she felt okay and she said not really. I offered to call someone for her, check her pulse, oxygen, and blood pressure but she refused. I gave her the VIS form she requested as well as a receipt from the shot to show the date of her immunization. She did not specify what date she went into/got out of the hospital. Before I could ask more questions she left because she wasn't feeling well and wanted her husband to take her home.
Patient had vaccine on 1/6/21 and have three  grand mal seizure on 1/12/21.  She was hospitalized and return to facility on 1/15/21.  Patient does  has history of seizure but the last one was three years ago.
Felt dizzy and nausea 10 to 15 after receiving shot; Felt dizzy and nausea 10 to 15 after receiving shot; This is a spontaneous report from a contactable pharmacist. An adult non-pregnant female patient of unknown age received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an intramuscular route of administration in the left arm on 11Apr2021 at 14:30, as a single dose for COVID-19 immunisation. Medical history was not reported. It was unknown whether the patient had any known allergies to food, medications or other products. It was unknown whether the patient received any other medications within two weeks of vaccination. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 11Apr2021, the patient felt dizzy and nausea 10 to 15 after receiving shot. The reporter had to call doctor to pick her up. No therapeutic measures were taken as a result of the events. The clinical outcome of the events felt dizzy and nausea 10 to 15 after receiving shot was resolving at the time of this report.  No follow-up attempts are possible. No further information is expected.
Dad state that had temp Friday thru Saturday. Sunday night, rash on body. On Monday, generalized vesicles, fluid filled, itchy.
Fatigue, muscular aches - arm swollen significantly. Slepts more than 24 hours over 1 1/2 days.
Fever 101.3F,  weakness, malaise, pain on the injection site, headache
fever; feverish and headachy; This is a spontaneous report from a contactable consumer from a Pfizer-sponsored program. A female patient of an unspecified age received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date were not reported), via an unspecified route of administration on 19Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced feverish and headachy on an unspecified date. The outcome of the events was unknown. The patient was asking if it was okay to take Tylenol.   Information about Lot / Batch number has been requested.
symptom feeling from the booster; This spontaneous case was reported by an other health care professional and describes the occurrence of VACCINATION COMPLICATION (symptom feeling from the booster) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (symptom feeling from the booster). At the time of the report, VACCINATION COMPLICATION (symptom feeling from the booster) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported No treatment medications were reported
Pt received vaccine on 10/11/2010. She stated that on 10/11/10 she experienced blurred vision, regurgitation, lower back pain, fever, gritty feeling in right eye, and increased glucose level. Pt recovered this on 10/12/10 stating feeling ok 10/12/10.
No adverse event. 10/15/22 Flublock administered instead of fluzone. Provider, self, notifeid 12/6/22. Report made
Pt devel a fever & redness @ inject site p/receiving either TTOx or Td adult use;
Extreme fatigue. Fainting. Vitamin deficiency (D, b12,) low hemoglobin, not previously low.
Vaccines went into 2-8 C thaw state on or about 24-Dec-2021 and administered on 15-Mar-2022; Received vaccine past its 30-days Exp date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received vaccine past its 30-days Exp date) and PRODUCT STORAGE ERROR (Vaccines went into 2-8 C thaw state on or about 24-Dec-2021 and administered on 15-Mar-2022) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     It was unknown if patient had any acute illnesses at the time of vaccination and up to one month before. It was unknown if the patient had chronic or long-standing health conditions.     On 15-Mar-2022 at 4:58 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 15-Mar-2022 at 4:58 PM,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Received vaccine past its 30-days Exp date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccines went into 2-8 C thaw state on or about 24-Dec-2021 and administered on 15-Mar-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received vaccine past its 30-days Exp date) and PRODUCT STORAGE ERROR (Vaccines went into 2-8 C thaw state on or about 24-Dec-2021 and administered on 15-Mar-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications information was reported.  It was unknown if any prescriptions, over-the-counter-medications, dietary supplements, or herbal remedies were being taken by the patient at the time of vaccination and/or at the time of the adverse event. It was unknown if other vaccines were given on the same day or within one month prior to any dose of Moderna COVID-19 Vaccine to the patient.  Patient received the booster dose.  It was reported that vaccines went into 2-8 C thaw state on or above 24-Dec-2021 and were administered up until the MFG expiry date of 04-Apr-2022.  No treatment medications were provided.   This case was linked to MOD-2022-542869 (Patient Link).
This spontaneous report as received from a certified medical assistant refers to a patient of unknown age and gender. On an unknown date, the patient was scheduled to complete a vaccination series with GARDASIL, for prophylaxis. On an unknown date the patient experienced drug dose omission, no adverse event and product availability issue. Additional information is not expected, as there was no consent to contact the reporter.
Patient could not take Zostovax because has immune disease.  Patient had shingles last September.  As soon as vaccine was administered it was very painful, a sharp pain going down to elbow.  Patient moved arm around to see if it helped.  Arm got red and hot--it felt like if bruised.  It was hard to lift arm across shoulder; like if hit with a bat.  Patient iced it for 2 days.   On 4th/5th day starting having a crawling nerve feeling like if was going to get shingles.  Sinusitis has gotten worse; feels like more sensitive than ever been.  It took about 10 days for arm to start to improve.  Patient has not contacted pharmacist or doctor at any time.    Will talk to doctor at next scheduled wellness check appt. Patient took some Tylenol.
Fever 101-102 began 7 days post vax on 04/10 with crankiness and irritability. No cough or URI.
patient was walking and lungs felt like they were on fire; has to cut walk down; pleurisy; feels short of breath; sore arm; This spontaneous case was reported by a nurse and describes the occurrence of CHEST PAIN (patient was walking and lungs felt like they were on fire), PAIN IN EXTREMITY (sore arm), GAIT DISTURBANCE (has to cut walk down), PLEURISY (pleurisy) and DYSPNOEA (feels short of breath) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     The patient's past medical history included Heart valve replacement (20 years ago). Concurrent medical conditions included Type 2 diabetes mellitus (controlled by diet and exercise, last A1C 5.5). Concomitant products included WARFARIN SODIUM (COUMADIN) for Heart valve replacement, FUROSEMIDE (LASIX [FUROSEMIDE]), ATORVASTATIN, DOCUSATE SODIUM (COLACE), METOPROLOL, POTASSIUM, LISINOPRIL, MULTIVITAMINS [VITAMINS NOS], TOPIRAMATE (TOPAMAX), CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000), CALCIUM and METFORMIN for an unknown indication.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On 15-Feb-2021, the patient experienced CHEST PAIN (patient was walking and lungs felt like they were on fire), GAIT DISTURBANCE (has to cut walk down), PLEURISY (pleurisy) and DYSPNOEA (feels short of breath). At the time of the report, CHEST PAIN (patient was walking and lungs felt like they were on fire), PAIN IN EXTREMITY (sore arm), GAIT DISTURBANCE (has to cut walk down), PLEURISY (pleurisy) and DYSPNOEA (feels short of breath) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient did not use any treatments medicines for the symptoms.
No known adverse effects.; a patient received an expired dose of VATQA; This spontaneous report has been received from a medical assistant referring to a patient of unknown age and gender. Information about medical history, concurrent conditions, concomitant therapies and drug allergies was not provided.      On 08-APR-2020, the patient was vaccinated with an expired dose of hepatitis a vaccine, inactivated (VAQTA) (lot #: S001360, expiration date: 06-MAR-2020; route and dose details were unknown) for prophylaxis (expired product administered). No known adverse effects.
1416: Pt states heart coming out [sic] and lips and tongue are numb.   1417: HR 108 SpO2 100% 1418: Benadryl 10 ml [25 mg] given.  1440: HR 85 SpO2 100%. I recommended she stay for at least 30 mins. Patient chose to leave against recommendation after Benadryl and assessment.
The HCP administered an expired Moderna Vaccine to the patient; This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (The HCP administered an expired Moderna Vaccine to the patient) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 049E21A and 939901) for COVID-19 vaccination.     No Medical History information was reported.   On 15-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Oct-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Oct-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (The HCP administered an expired Moderna Vaccine to the patient). At the time of the report, EXPIRED PRODUCT ADMINISTERED (The HCP administered an expired Moderna Vaccine to the patient) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were mentioned. No treatment details were reported.
Discomfort at injection site almost immediately & then a real weird nausea at 36 hrs that lasted 12 hrs - tired
Hospitalization for COVID of a fully vaccinated patient.  Unknown dates of vaccinations and lot number
Low fever 100.5 F; This is a spontaneous report received from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA vaccine; Lot number: EL3247), via an unspecified route of administration in the left arm on 18Mar2021 at 12:00 (at the age of 48-years-old), as a single dose for COVID-19 immunisation. Medical history reported as not applicable. Concomitant medications were not reported. Th patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA vaccine; Lot number: EL-3247), via an unspecified route of administration in the left arm on 24Feb2021 at 12:00 (at the age of 48-years-old), as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested positive for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. On 19Mar2021 at 13:00, the patient had low fever 100.5 F. Therapeutic measures were taken as a result of event low grade fever and included treatment with two ADVIL tablets. The event did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. The clinical outcome of event low fever 100.5 F was resolved on an unspecified date in Mar2021.   No follow-up attempts are needed. No further information is expected.
This is a spontaneous report from a contactable Nurse via Pfizer sales representative.  A 16-year-old female patient of an unspecified ethnicity received the first dose of TRUMENBA in her left arm, via an unspecified route of administration on an unspecified date at single dose for immunisation.  Concomitant medication included MENACTRA administered on the same day in the same arm. No underlying conditions were reported. The patient medical history was not reported. The patient experienced redness pain and swelling at the injection site on the same day of vaccination. In the evening it appeared as a big red square mark at the site. On the same day, a rash appeared on her left side of neck. The next morning the rash expanded up onto her lower left cheek and ear lobe was red and swollen. She was treated with oral steroids. Events took place after use of product. The outcome of the events was unknown.
Local swelling, redness, itching started on arm 4-6 hours after flu vaccine administration. No fever, dysphagia, wheeze, SOB or any systemic symptoms.
ADMINISTRATION ERROR, WRONG DOSE, PATIENT SHOULD HAVE GOTTEN PFIZER BIVALENT 5-11YEARS OLD, NOT PFIZER BIVALENT 12+
Anaphylaxis with respiratory distress about 10-15 minutes after vaccination with DTAP-IPV, MMR, VARIVAX. Required epinephrine, O2, albuterol, BENADRYL, SOLUMEDROL.
pt recv vax;to ER w/ HA & T of 100.4;vomited;tx w/ morphine; CT scan showed sinusitis; spinal tap performed but results not reported;
Puffy eyelids, particularly the right eyelid, without erythema to the eyelid, injected conjunctivae (right more than left), runny nose.
Records incomplete, vaccines were given as they were due. Discovered later an old record with all the vaccines given so patient had received duplicate vaccines.
Site: Pain at Injection Site-Mild, Systemic: Allergic: Anaphylaxis-Medium, Systemic: Allergic: Difficulty Swallowing, Throat Tightness-Mild
The day after the shot I had a bad headache fever of 102 and body aches.  That seemed to subside the next day except for a mild headache.  The following day, or the 3rd day after the shot, I had several bouts of what I will call extreme heartburn.  Severe burning sensation across chest after eating and tingling down both arms. Painful and physically limiting on Thursday 4/15/21.  On Friday the "heartburn" returned after eating but a little less severe.  Slight headache was still present.  Saturday and Sunday were progressively better.  Monday 4/19/21, almost back on a regular diet.  Slight tenderness in abdominal area when palpated.
11MAR91 mom c/o intermittent temp x several days p/immun; highest temp recorded 102F; referred for med eval per MD normal rxn;
Caregiver came in on 05/06/2022 due to complaint of numbness and tingling in Left lower medial arm extending from the level of the elbow to the 4th and 5th digits. Symptom onset 3 days prior (05/03/2022). ED doctor seen regarding this injury 05/06/2022; given referral by ED MD for neuro providers.  Caregiver concerned that his symptoms may be due to his  Hep B vaccination and blood draw on 4/22/2022. Hep B vaccination was given IM in Left Deltoid. Per Caregiver, soreness at injection site post vaccination x 1 day; relieved by OTC advil (ibuprofen). Blood draw done in  Left AC, 1 successful attempt; no S/Sx after.